Charles Schwab’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.69B Buy
19,177,219
+142,917
+0.8% +$33.3M 0.72% 30
2025
Q4
$3.94B Buy
19,034,302
+22,243
+0.1% +$4.4M 0.61% 31
2025
Q3
$3.52B Buy
19,012,059
+60,722
+0.3% +$10.4M 0.56% 35
2025
Q2
$2.89B Buy
18,951,337
+67,517
+0.4% +$10.4M 0.5% 39
2025
Q1
$3.13B Buy
18,883,820
+696,738
+4% +$109M 0.59% 36
2024
Q4
$2.63B Buy
18,187,082
+547,714
+3% +$84.9M 0.48% 41
2024
Q3
$2.86B Buy
17,639,368
+102,502
+0.6% +$16.3M 0.55% 37
2024
Q2
$2.56B Buy
17,536,866
+1,358,934
+8% +$202M 0.49% 42
2024
Q1
$2.54B Buy
16,177,932
+232,399
+1% +$37M 0.59% 32
2023
Q4
$2.48B Buy
15,945,533
+241,799
+2% +$37.1M 0.63% 30
2023
Q3
$2.43B Sell
15,703,734
-1,419,551
-8% -$234M 0.7% 26
2023
Q2
$2.81B Sell
17,123,285
-23,034
-0.1% -$3.72M 0.8% 23
2023
Q1
$2.64B Buy
17,146,319
+59,748
+0.3% +$9.65M 0.8% 24
2022
Q4
$2.99B Buy
17,086,571
+174,516
+1% +$30.1M 0.96% 13
2022
Q3
$2.76B Buy
16,912,055
+343,752
+2% +$58.2M 0.99% 10
2022
Q2
$2.94B Sell
16,568,303
-620,926
-4% -$111M 1.02% 10
2022
Q1
$3.05B Buy
17,189,229
+328,297
+2% +$55.9M 0.92% 12
2021
Q4
$2.88B Buy
16,860,932
+431,394
+3% +$70.6M 0.85% 14
2021
Q3
$2.65B Buy
16,429,538
+176,155
+1% +$30.1M 0.87% 11
2021
Q2
$2.68B Buy
16,253,383
+356,306
+2% +$59M 0.89% 9
2021
Q1
$2.61B Buy
15,897,077
+222,457
+1% +$36M 0.96% 8
2020
Q4
$2.47B Buy
15,674,620
+37,447
+0.2% +$5.53M 0.98% 6
2020
Q3
$2.33B Sell
15,637,173
-787,490
-5% -$117M 1.07% 5
2020
Q2
$2.31B Sell
16,424,663
-145,704
-0.9% -$21.2M 1.13% 5
2020
Q1
$2.17B Buy
16,570,367
+4,223,328
+34% +$599M 1.28% 4
2019
Q4
$1.8B Buy
12,347,039
+88,125
+0.7% +$12M 0.97% 11
2019
Q3
$1.59B Sell
12,258,914
-140,906
-1% -$18.6M 0.94% 13
2019
Q2
$1.73B Buy
12,399,820
+209,429
+2% +$29M 1.05% 7
2019
Q1
$1.7B Buy
12,190,391
+440,300
+4% +$59M 1.09% 5
2018
Q4
$1.52B Buy
11,750,091
+195,991
+2% +$27.3M 1.16% 6
2018
Q3
$1.6B Buy
11,554,100
+523,937
+5% +$69.6M 1.06% 6
2018
Q2
$1.34B Buy
11,030,163
+384,098
+4% +$47.9M 0.97% 8
2018
Q1
$1.36B Sell
10,646,065
-1,930,295
-15% -$261M 1.06% 7
2017
Q4
$1.76B Buy
12,576,360
+551,632
+5% +$76.8M 1.39% 4
2017
Q3
$1.56B Buy
12,024,728
+401,089
+3% +$53.2M 1.37% 4
2017
Q2
$1.54B Buy
11,623,639
+473,300
+4% +$60.4M 1.44% 4
2017
Q1
$1.39B Buy
11,150,339
+201,703
+2% +$24.1M 1.39% 4
2016
Q4
$1.26B Buy
10,948,636
+341,813
+3% +$39.5M 1.38% 4
2016
Q3
$1.25B Buy
10,606,823
+361,165
+4% +$43.8M 1.47% 4
2016
Q2
$1.24B Buy
10,245,658
+230,042
+2% +$26.1M 1.55% 4
2016
Q1
$1.08B Buy
10,015,616
+227,603
+2% +$23.6M 1.42% 4
2015
Q4
$1.01B Buy
9,788,013
+518,746
+6% +$52.2M 1.35% 4
2015
Q3
$866M Sell
9,269,267
-86,408
-0.9% -$8.36M 1.28% 5
2015
Q2
$912M Buy
9,355,675
+91,991
+1% +$9.21M 1.26% 4
2015
Q1
$932M Buy
9,263,684
+288,633
+3% +$29.4M 1.31% 5
2014
Q4
$939M Buy
8,975,051
+216,443
+2% +$22.8M 1.41% 4
2014
Q3
$934M Buy
8,758,608
+128,517
+1% +$13.3M 1.54% 4
2014
Q2
$903M Sell
8,630,091
-25,598
-0.3% -$2.59M 1.52% 3
2014
Q1
$850M Buy
8,655,689
+148,511
+2% +$13.8M 1.52% 3
2013
Q4
$779M Buy
8,507,178
+90,857
+1% +$8.37M 1.48% 3
2013
Q3
$736M Buy
8,416,321
+1,396,452
+20% +$125M 1.5% 4
2013
Q2
$608M Buy
+7,019,869
New +$596M 1.36% 6

Other funds holding JNJ

Charles Schwab's JNJ Position: Q1 2026 in Review

Charles Schwab increased its Johnson & Johnson (JNJ) stake by 0.75% in Q1 2026, buying an estimated $33.3M and bringing the position to 19,177,219 shares worth $4.69B. The position accounts for 0.72% of the portfolio, ranked #30.

Charles Schwab first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Charles Schwab held 19,177,219 shares of Johnson & Johnson worth $4.69B as of Q1 2026.
  • Charles Schwab bought 142,917 Johnson & Johnson shares in Q1 2026, an estimated $33.3M.
  • Johnson & Johnson made up 0.72% of Charles Schwab's portfolio in Q1 2026, its #30 holding.
  • Charles Schwab first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.